INO 240726 11.00P (INO240726P11000) Stock Options, News & Quotes

$Inovio Pharmaceuticals(INO.US)$ Company Announced That INO-3107, Has Been Designated an Innovative Medicine as Part of the U.K.'s Innovative Licensing and Access Pathway

Trytosaveabit

May 13 15:24

Make note of dates upcoming!

$Inovio Pharmaceuticals(INO.US)$ INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
• BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
• Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
• Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...

Trytosaveabit

Apr 15 17:41

Ouch! Hehehe

$Inovio Pharmaceuticals(INO.US)$ Inovio Pharmaceuticals Inc - Pricing of an Underwritten Offering of 2.5 Mln Shares of Its Common Stock at an Offering Price of $7.693 per Share

Trytosaveabit

Apr 15 17:40

Update! Humpfff! Hehehe

$Inovio Pharmaceuticals(INO.US)$ Inovio Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants